Multimodality Imaging Reveals Divergent Responses of Left and Right Heart to Treatment in Cardiac Amyloidosis

JACC Case Rep. 2019 Oct 16;1(3):360-366. doi: 10.1016/j.jaccas.2019.07.034. eCollection 2019 Oct.

Abstract

Cardiac amyloidosis is associated with very high morbidity and mortality. Only if treated early, cardiac amyloidosis responds well to therapy, and early recognition with a full differential diagnostic workup including multimodality imaging is therefore critical at first presentation. Closely meshed clinical monitoring and imaging are indispensable to ensure optimal individualized treatment. (Level of Difficulty: Beginner.).

Keywords: AL, amyloid light chain; CA, cardiac amyloidosis; CMR, cardiac magnetic resonance; EMB, endomyocardial biopsy; LGE, late gadolinium enhancement; LV, left ventricular; NT-pro-BNP, N-terminal pro–B-type natriuretic peptide; cardiac amyloidosis; cardiomyopathies; cardiovascular inflammation; endomyocardial biopsy; immunosuppressive therapy; myocardial imaging.

Publication types

  • Case Reports